Information Provided By: 
Fly News Breaks for October 21, 2016
IMAX
Oct 21, 2016 | 08:35 EDT
Following Q3 results, Roth Capital analyst Darren Aftahi says IMAX's "strong" theater signings and install performance, which appear will continue into 2017, should set the stock up well as the box office looks to start improving later in Q4 and over the next 24 months. The analyst reiterates a Buy rating and $38 price target on the shares.
News For IMAX From the Last 2 Days
